{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:31:43Z","timestamp":1777480303033,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2023JJ60513"],"award-info":[{"award-number":["2023JJ60513"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00408-024-00741-y","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T17:02:36Z","timestamp":1724778156000},"page":"673-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increased Pneumonia Risk Associated with Concomitant Use of Inhaled Corticosteroids and Benzodiazepines: A Pharmacovigilance Analysis"],"prefix":"10.1007","volume":"202","author":[{"given":"Junlong","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-586X","authenticated-orcid":false,"given":"Guoping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"issue":"9","key":"741_CR1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1513\/AnnalsATS.201809-607OC","volume":"16","author":"JA Krishnan","year":"2019","unstructured":"Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L et al (2019) Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices. Ann Am Thorac Soc 16(9):1143\u20131150","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"741_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1183\/09031936.06.00025805","volume":"27","author":"AD Lopez","year":"2006","unstructured":"Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS et al (2006) Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 27(2):397\u2013412","journal-title":"Eur Respir J"},{"key":"741_CR3","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.2147\/JIR.S417801","volume":"16","author":"L Liu","year":"2023","unstructured":"Liu L, Zhou L, Wang LL, Zheng PD, Zhang FQ, Mao ZY et al (2023) Programmed cell death in asthma: apoptosis, autophagy, pyroptosis, ferroptosis, and necroptosis. J Inflamm Res 16:2727\u20132754","journal-title":"J Inflamm Res"},{"issue":"1","key":"741_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12931-015-0260-0","volume":"16","author":"A Higham","year":"2015","unstructured":"Higham A, Booth G, Lea S, Southworth T, Plumb J, Singh D (2015) The effects of corticosteroids on COPD lung macrophages: a pooled analysis. Respir Res 16(1):98","journal-title":"Respir Res"},{"issue":"5","key":"741_CR5","first-page":"Cd013518","volume":"5","author":"I Crossingham","year":"2021","unstructured":"Crossingham I, Turner S, Ramakrishnan S, Fries A, Gowell M, Yasmin F et al (2021) Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Cochrane Database Syst Rev 5(5):Cd013518","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"741_CR6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jaci.2008.02.029","volume":"121","author":"WW Busse","year":"2008","unstructured":"Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen YZ, Lamm CJ et al (2008) The inhaled steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 121(5):1167\u20131174","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"741_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJMoa063070","volume":"356","author":"PM Calverley","year":"2007","unstructured":"Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW et al (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356(8):775\u2013789","journal-title":"N Engl J Med"},{"issue":"3","key":"741_CR8","first-page":"Cd002991","volume":"3","author":"IA Yang","year":"2023","unstructured":"Yang IA, Ferry OR, Clarke MS, Sim EH, Fong KM (2023) Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 3(3):Cd002991","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"741_CR9","first-page":"795","volume":"11","author":"MH Kim","year":"2019","unstructured":"Kim MH, Rhee CK, Shim JS, Park SY, Yoo KH, Kim BY et al (2019) Inhaled corticosteroids in asthma and the risk of pneumonia allergy, asthma. Immunol Res 11(6):795\u2013805","journal-title":"Immunol Res"},{"issue":"6","key":"741_CR10","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1378\/chest.13-0871","volume":"144","author":"T McKeever","year":"2013","unstructured":"McKeever T, Harrison TW, Hubbard R, Shaw D (2013) Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study. Chest 144(6):1788\u20131794","journal-title":"Chest"},{"issue":"6","key":"741_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/thoraxjnl-2021-217930","volume":"77","author":"C Janson","year":"2022","unstructured":"Janson C (2022) Inhaled corticosteroids in COPD: risk and benefits. Thorax 77(6):530\u2013531","journal-title":"Thorax"},{"issue":"3","key":"741_CR12","doi-asserted-by":"publisher","first-page":"1701582","DOI":"10.1183\/13993003.01582-2017","volume":"50","author":"JD Chalmers","year":"2017","unstructured":"Chalmers JD, Keir HR (2017) 10 Years since TORCH: shining a new light on the risks of inhaled corticosteroids in COPD. Eur Respir J 50(3):1701582","journal-title":"Eur Respir J"},{"issue":"1","key":"741_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4049\/jimmunol.1402217","volume":"195","author":"VR Stolberg","year":"2015","unstructured":"Stolberg VR, McCubbrey AL, Freeman CM, Brown JP, Crudgington SW, Taitano SH et al (2015) Glucocorticoid-augmented efferocytosis inhibits pulmonary pneumococcal clearance in mice by reducing alveolar macrophage bactericidal function. J Immunol 195(1):174\u2013184","journal-title":"J Immunol"},{"issue":"2","key":"741_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1183\/09031936.00008014","volume":"44","author":"NT Vozoris","year":"2014","unstructured":"Vozoris NT, Fischer HD, Wang X, Stephenson AL, Gershon AS, Gruneir A et al (2014) Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 44(2):332\u2013340","journal-title":"Eur Respir J"},{"issue":"27","key":"741_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001110","volume":"94","author":"WS Chung","year":"2015","unstructured":"Chung WS, Lai CY, Lin CL, Kao CH (2015) Adverse respiratory events associated with hypnotics use in patients of chronic obstructive pulmonary disease: a population-based case-control study. Medicine 94(27):e1110","journal-title":"Medicine"},{"issue":"2","key":"741_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/thoraxjnl-2012-202374","volume":"68","author":"E Obiora","year":"2013","unstructured":"Obiora E, Hubbard R, Sanders RD, Myles PR (2013) The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort. Thorax 68(2):163\u2013170","journal-title":"Thorax"},{"issue":"7","key":"741_CR17","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1097\/CCM.0b013e31827c0c8d","volume":"41","author":"RD Sanders","year":"2013","unstructured":"Sanders RD, Godlee A, Fujimori T, Goulding J, Xin G, Salek-Ardakani S et al (2013) Benzodiazepine augmented \u03b3-amino-butyric acid signaling increases mortality from pneumonia in mice. Crit Care Med 41(7):1627\u20131636","journal-title":"Crit Care Med"},{"issue":"6","key":"741_CR18","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.jaip.2018.02.002","volume":"6","author":"J Sastre","year":"2018","unstructured":"Sastre J, Crespo A, Fernandez-Sanchez A, Rial M, Plaza V (2018) Anxiety, depression, and asthma control: changes after standardized treatment. J Allergy Clin Immunol Pract 6(6):1953\u20131959","journal-title":"J Allergy Clin Immunol Pract"},{"key":"741_CR19","doi-asserted-by":"publisher","first-page":"106089","DOI":"10.1016\/j.rmed.2020.106089","volume":"171","author":"SAA Vikjord","year":"2020","unstructured":"Vikjord SAA, Brumpton BM, Mai XM, Vanfleteren L, Langhammer A (2020) The association of anxiety and depression with mortality in a COPD cohort. The HUNT study, Norway. Respir Med 171:106089","journal-title":"Respir Med"},{"issue":"4","key":"741_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40264-014-0146-y","volume":"37","author":"PM Tregunno","year":"2014","unstructured":"Tregunno PM, Fink DB, Fernandez-Fernandez C, L\u00e1zaro-Bengoa E, Nor\u00e9n GN (2014) Performance of probabilistic method to detect duplicate individual case safety reports. Drug Saf 37(4):249\u2013258","journal-title":"Drug Saf"},{"key":"741_CR21","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3389\/fphar.2019.01319","volume":"10","author":"Y Noguchi","year":"2019","unstructured":"Noguchi Y, Tachi T, Teramachi H (2019) Review of statistical methodologies for detecting drug-drug interactions using spontaneous reporting systems. Front Pharmacol 10:1319","journal-title":"Front Pharmacol"},{"issue":"2","key":"741_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.clpt.6100258","volume":"82","author":"JS Almenoff","year":"2007","unstructured":"Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJ, Yuen N (2007) Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther 82(2):157\u2013166","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"741_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST (2004) The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf 13(8):519\u2013523","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"741_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2125.2007.02900.x","volume":"64","author":"BT Thakrar","year":"2007","unstructured":"Thakrar BT, Grundschober SB, Doessegger L (2007) Detecting signals of drug-drug interactions in a spontaneous reports database. Br J Clin Pharmacol 64(4):489\u2013495","journal-title":"Br J Clin Pharmacol"},{"key":"741_CR25","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.3389\/fpsyg.2019.02215","volume":"10","author":"K Jung","year":"2019","unstructured":"Jung K, Lee J, Gupta V, Cho G (2019) Comparison of bootstrap confidence interval methods for GSCA using a Monte Carlo simulation. Front Psychol 10:2215","journal-title":"Front Psychol"},{"key":"741_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.910205","volume":"13","author":"H Akimoto","year":"2022","unstructured":"Akimoto H, Nagashima T, Minagawa K, Hayakawa T, Takahashi Y, Asai S (2022) Detection of synergistic interaction on an additive scale between two drugs on abnormal elevation of serum alanine aminotransferase using machine-learning algorithms. Front Pharmacol 13:910205","journal-title":"Front Pharmacol"},{"issue":"7","key":"741_CR27","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1164\/rccm.200508-1321OC","volume":"173","author":"NC Barnes","year":"2006","unstructured":"Barnes NC, Qiu YS, Pavord ID, Parker D, Davis PA, Zhu J et al (2006) Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med 173(7):736\u2013743","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"741_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207675","volume":"14","author":"KA Provost","year":"2019","unstructured":"Provost KA, Smith M, Miller-Larsson A, Gudleski GD, Sethi S (2019) Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate. PLoS ONE 14(1):e0207675","journal-title":"PLoS ONE"},{"issue":"15","key":"741_CR29","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.1007\/s00018-021-03881-z","volume":"78","author":"AK Bhandage","year":"2021","unstructured":"Bhandage AK, Barragan A (2021) GABAergic signaling by cells of the immune system: more the rule than the exception. Cell Mol Life Sci: CMLS 78(15):5667\u20135679","journal-title":"Cell Mol Life Sci: CMLS"},{"issue":"1","key":"741_CR30","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/TA.0000000000003134","volume":"91","author":"E Skicki","year":"2021","unstructured":"Skicki E, Morgan M, Brown C, Bradburn E, Rogers F (2021) Benzodiazepines increase the likelihood of both infectious and thrombotic complications. J Trauma Acute Care Surg 91(1):206\u2013211","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"741_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1073\/pnas.0405621102","volume":"102","author":"JK Rowlett","year":"2005","unstructured":"Rowlett JK, Platt DM, Lelas S, Atack JR, Dawson GR (2005) Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci USA 102(3):915\u2013920","journal-title":"Proc Natl Acad Sci USA"},{"key":"741_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.128637","volume":"62","author":"LK Golani","year":"2022","unstructured":"Golani LK, Yeunus Mian M, Ahmed T, Pandey KP, Mondal P, Sharmin D et al (2022) Rationalizing the binding and \u03b1 subtype selectivity of synthesized imidazodiazepines and benzodiazepines at GABAA receptors by using molecular docking studies. Bioorg Med Chem Lett 62:128637","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"741_CR33","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/bph.12362","volume":"171","author":"F Franconi","year":"2014","unstructured":"Franconi F, Campesi I (2014) Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women. Br J Pharmacol 171(3):580\u2013594","journal-title":"Br J Pharmacol"},{"issue":"1","key":"741_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12931-019-1262-0","volume":"21","author":"BF Hartley","year":"2020","unstructured":"Hartley BF, Barnes NC, Lettis S, Compton CH, Papi A, Jones P (2020) Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis. Respir Res 21(1):5","journal-title":"Respir Res"},{"issue":"5","key":"741_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.clpt.2006.08.014","volume":"80","author":"M Chen","year":"2006","unstructured":"Chen M, Ma L, Drusano GL, Bertino JS Jr, Nafziger AN (2006) Sex differences in CYP3A activity using intravenous and oral midazolam. Clin Pharmacol Ther 80(5):531\u2013538","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"741_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ccm.2020.05.006","volume":"41","author":"T Mkorombindo","year":"2020","unstructured":"Mkorombindo T, Dransfield MT (2020) Inhaled corticosteroids in chronic obstructive pulmonary disease: benefits and risks. Clin Chest Med 41(3):475\u2013484","journal-title":"Clin Chest Med"},{"key":"741_CR37","doi-asserted-by":"crossref","unstructured":"Aggarwal B, Jones P, Casas A, Gomes M, Juthong S, Litewka D et al. (2024) Association between increased risk of pneumonia with ICS in COPD: a continuous variable analysis of patient factors from the IMPACT study. Pulmonary therapy","DOI":"10.1007\/s41030-024-00255-1"},{"key":"741_CR38","unstructured":"Global strategy for prevention, diagnosis and management of COPD: 2024 Report. The global initiative for chronic obstructive lung disease; 2024 [cited 2024 April]; Available from: https:\/\/goldcopd.org\/2024-gold-report\/"},{"key":"741_CR39","unstructured":"Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma; 2024 [cited 2024 April]; Available from: www.ginasthma.org"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-024-00741-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-024-00741-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-024-00741-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T06:06:55Z","timestamp":1727330815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-024-00741-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s00408-024-00741-y","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}